Bristol-Myers Squibb and Nvidia built an AI supercomputer for drug discovery that cut computing costs 55%, joining a pharma industry AI infrastructure race.

Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.

Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.